Category

Daily Briefs

Daily Brief Equity Bottom-Up: Yaskawa (6506 JP): Start of a New Factory Automation Growth Cycle and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Yaskawa (6506 JP): Start of a New Factory Automation Growth Cycle
  • Acadia Healthcare Company Inc.: Initiation Of Coverage – Investment in technology to optimize infrastructure and clinical outcomes! – Major Drivers
  • The Boston Beer Company Inc.: Initiation Of Coverage – Is Its Positioning In The Hard Seltzer Market Its Biggest Competitive Advantage? – Major Drivers
  • Tenet Healthcare Corporation: Initiation Of Coverage – Its Focus on Higher Acuity Services in Hospitals & Other Core Strategies! – Major Drivers
  • DENTSPLY SIRONA Inc.: Initiation Of Coverage – What Is Its Core Business Strategy? – Major Drivers
  • Duplicate of Tenet Healthcare Corporation: Initiation Of Coverage – Its Focus on Higher Acuity Services in Hospitals & Other Core Strategies! – Major Drivers
  • Elanco Animal Health: Initiation Of Coverage – A Story Of Concentration on Pet Health and Livestock Sustainability! – Major Drivers
  • Fresenius Medical Care: Initiation Of Coverage – Innovation with AR in Dialysis Training & 4 Other Major Drivers
  • Globus Medical Inc.: Initiation Of Coverage – Increasing Portfolio Range & 3 Critical Growth Factors
  • Graphic Packaging Holding Company: Initiation Of Coverage – These Are The 3 Biggest Challenges In Its Path! – Major Drivers


Yaskawa (6506 JP): Start of a New Factory Automation Growth Cycle

By Scott Foster

  • The outlook for factory automation is improving with inventory clearance, the upturn in the semiconductor industry and an AI-enhanced response to the labor shortage.
  • Yaskawa’s margins should continue to rise with renewed growth in Robotics, efficiency gains and an upgraded product line. 
  • Valuation stretched at 30x EPS guidance for FY Feb-25, but current weakness looks like a long term buying opportunity.

Acadia Healthcare Company Inc.: Initiation Of Coverage – Investment in technology to optimize infrastructure and clinical outcomes! – Major Drivers

By Baptista Research

  • Acadia Healthcare delivered a robust financial performance for 2023, marked by a 12.2% annual revenue growth, 13.1% adjusted EBITDA growth, and 14.3% adjusted EPS growth compared to 2022.
  • In the fourth quarter, its same-facility revenue rose by 10.3% on the back of rate improvements and patient day growth.
  • Acadia also saw consistent improvement in its labor trends throughout 2023.

The Boston Beer Company Inc.: Initiation Of Coverage – Is Its Positioning In The Hard Seltzer Market Its Biggest Competitive Advantage? – Major Drivers

By Baptista Research

  • The Boston Beer Company’s Fourth Quarter 2023 Earnings revealed an operational performance meeting the midpoint of their forecast, with depletions down by 6% for the year and gross margins achieving an improvement of 120 basis points.
  • However, net loss for the quarter indicated challenges, standing at $18.1 million, or $1.49 per diluted share.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Tenet Healthcare Corporation: Initiation Of Coverage – Its Focus on Higher Acuity Services in Hospitals & Other Core Strategies! – Major Drivers

By Baptista Research

  • Tenet Healthcare’s Q4 2023 earnings indicated a strong performance, with net operating revenues of $20.5 billion, and consolidated adjusted EBITDA of $3.54 billion, which translates into an attractive 17.2% adjusted EBITDA margin.
  • The company has demonstrated its ability to maintain profitability while focusing on quality and innovation.
  • Yet, some challenges were also mentioned during the earnings call.

DENTSPLY SIRONA Inc.: Initiation Of Coverage – What Is Its Core Business Strategy? – Major Drivers

By Baptista Research

  • Examining the fourth quarter 2023 earnings for Dentsply Sirona reveals an investment thesis that emphasizes the company’s successful strategies, robust performance and rigorous financial discipline, alongside ambitious future business growth targets and consistent value creation for its stakeholders.
  • Starting with the positives, Dentsply Sirona achieved over 2% organic sales growth for 2023, outperforming projections via growth in three of its four business segments.
  • Notably, its orthodontic business experienced double-digit growth with both Byte and SureSmile.

Duplicate of Tenet Healthcare Corporation: Initiation Of Coverage – Its Focus on Higher Acuity Services in Hospitals & Other Core Strategies! – Major Drivers

By Baptista Research

  • Chemed Corporation reported their fourth quarter 2023 earnings with continued improvement in their VITAS operational metrics, including a 7% increase in admissions over the prior year period and an average daily census of 1,918.
  • This is an 11% increase in comparison to the prior year and suggests that a hiring and retention program initiated in 2022 to remedy any potential worker turnover and expand clinical workforce capacity has been successful in maintaining VITAS’ operational performance.
  • Baptista Research looks to evaluate the different factors that could influence the company’s price in the near future and attempts to carry out an independent valuation of the company using a Discounted Cash Flow (DCF) methodology.

Elanco Animal Health: Initiation Of Coverage – A Story Of Concentration on Pet Health and Livestock Sustainability! – Major Drivers

By Baptista Research

  • In Q4 2023, Elanco Animal Health reported a 5% constant currency revenue growth, driven by innovations, the strength of the farm animal business, improved conditions in the European Pet Health retail market, and increased pricing.
  • The strong performance in 2023 indicates that the company’s innovation, portfolio, and productivity strategy are working, leading to confidence in the potential success of future investments.
  • Going into 2024, the company aims to focus on three priorities: sustained revenue growth, innovation, and improved cash conversion.

Fresenius Medical Care: Initiation Of Coverage – Innovation with AR in Dialysis Training & 4 Other Major Drivers

By Baptista Research

  • Fresenius Medical Care’s Q4 2023 earnings highlighted the progress made against their strategic plan that was set out a year prior.
  • The plan focused on significant structural, operational and cultural changes, with the operating model being transformed at the start of 2023.
  • This allowed the company to introduce a new financial report with increased transparency, which reflected a commitment to their operational turnaround initiatives that aided organic growth in both segments and improved operational performance.

Globus Medical Inc.: Initiation Of Coverage – Increasing Portfolio Range & 3 Critical Growth Factors

By Baptista Research

  • Globus Medical, a leading musculoskeletal solutions provider, has reported record revenues of $1.569 billion for the full year 2023, marking a growth of 53% compared to the previous year.
  • The strong performance includes four months of sales after its merger with NuVasive.
  • This remarkable growth maintained the company’s industry-leading profitability, generating a record non-GAAP EPS of $2.32 and an adjusted EBITDA of 30%.

Graphic Packaging Holding Company: Initiation Of Coverage – These Are The 3 Biggest Challenges In Its Path! – Major Drivers

By Baptista Research

  • Globus Medical, a leading musculoskeletal solutions provider, has reported record revenues of $1.569 billion for the full year 2023, marking a growth of 53% compared to the previous year.
  • The strong performance includes four months of sales after its merger with NuVasive.
  • This remarkable growth maintained the company’s industry-leading profitability, generating a record non-GAAP EPS of $2.32 and an adjusted EBITDA of 30%.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: Out of the Box: 6 Reasons the Fed Will Be Hiking Rates in 2024 and more

By | Daily Briefs, Macro

In today’s briefing:

  • Out of the Box: 6 Reasons the Fed Will Be Hiking Rates in 2024
  • The Weekly Market Monitor – Gold Bugs, Debt Bubbles, and Volatility Bites
  • Portfolio Watch: The Real World Is Reflating Again


Out of the Box: 6 Reasons the Fed Will Be Hiking Rates in 2024

By Ulrik Simmelholt

  • Even though the Santa rally in US STIRS has largely been reversed, markets are still pricing in 2.5 full cuts by the end of this year or so with the first to come around summer time.
  • Currently, one of the most unappreciated risks by markets would be the Fed actually hiking rates in 2024 and thus we thought we would present 6 compelling and thought provoking arguments for why the Fed hiking in 2024 might not be impossible after all (our base case is a hold).
  • The first argument has to do with year-on-year inflation seemingly having reached its equilibrium at 3%, a range in which it has found itself for the last year or so.

The Weekly Market Monitor – Gold Bugs, Debt Bubbles, and Volatility Bites

By Jeroen Blokland

  • This week, the price of gold surged past USD 2,300 per Troy Ounce for the first time, and it was not because Western investors were rushing in.
  • Equity markets refuse to decline due to excessive fiscal stimulus, central bank eagerness to cut rates, and improving economic momentum.
  • Despite falling bond volatility, the MOVE index remains elevated relative to the VIX index, a sign of changing times.

Portfolio Watch: The Real World Is Reflating Again

By Elias Lisberg Glistrup

  • Welcome to this week’s rundown of our portfolio, its performance, and our most clear-cut conviction for the period ahead.
  • The cocktail of better economic activity and geopolitical tensions provided tailwinds for our long crude bet, which reached its take profit level Tuesday, and hence we are out of our oil position with a significant profit.
  • Most notably, and reflecting our still cyclically tilted portfolio allocations, we see growth trending higher in the cyclical parts of the economy through April on our models and nowcasts.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Japan: Kokusai Electric , JSR Corp, Yaskawa Electric, Rakuten and more

By | Daily Briefs, Japan

In today’s briefing:

  • Weekly Deals Digest (07 Apr) – Kokusai Electric, HD Hyundai Marine, Langham, Jastec, JSR, Best World
  • (Mostly) Asia-Pac M&A: Austal, Best World, Isetan Singapore, Langham Hospitality, Azure, Genex Power
  • Yaskawa (6506 JP): Start of a New Factory Automation Growth Cycle
  • Last Week in Event SPACE: JSR, Austal, Rakuten, Hyundai Home Shopping, Hanmi Science


Weekly Deals Digest (07 Apr) – Kokusai Electric, HD Hyundai Marine, Langham, Jastec, JSR, Best World

By Arun George


(Mostly) Asia-Pac M&A: Austal, Best World, Isetan Singapore, Langham Hospitality, Azure, Genex Power

By David Blennerhassett


Yaskawa (6506 JP): Start of a New Factory Automation Growth Cycle

By Scott Foster

  • The outlook for factory automation is improving with inventory clearance, the upturn in the semiconductor industry and an AI-enhanced response to the labor shortage.
  • Yaskawa’s margins should continue to rise with renewed growth in Robotics, efficiency gains and an upgraded product line. 
  • Valuation stretched at 30x EPS guidance for FY Feb-25, but current weakness looks like a long term buying opportunity.

Last Week in Event SPACE: JSR, Austal, Rakuten, Hyundai Home Shopping, Hanmi Science

By David Blennerhassett

  • Murakami to tender stake in JSR Corp (4185 JP)? Maybe the “double arb”: i.e. short on swap, long on cash, will tender the cash, remain short the back end.
  • Austal Ltd (ASB AU) rejected (for now) Hanwha Ocean (042660 KS)‘s bid based on regulatory concerns.  Hanwha reckons these should not be an issue.
  • If you can tolerate owning the mobile biz, buy Rakuten (4755 JP) on dips. If not, avoid Rakuten Group and Rakuten Bank short-term; buy Rakuten Bank on larger dips.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: (Mostly) Asia-Pac M&A: Austal and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • (Mostly) Asia-Pac M&A: Austal, Best World, Isetan Singapore, Langham Hospitality, Azure, Genex Power
  • Last Week in Event SPACE: JSR, Austal, Rakuten, Hyundai Home Shopping, Hanmi Science


(Mostly) Asia-Pac M&A: Austal, Best World, Isetan Singapore, Langham Hospitality, Azure, Genex Power

By David Blennerhassett


Last Week in Event SPACE: JSR, Austal, Rakuten, Hyundai Home Shopping, Hanmi Science

By David Blennerhassett

  • Murakami to tender stake in JSR Corp (4185 JP)? Maybe the “double arb”: i.e. short on swap, long on cash, will tender the cash, remain short the back end.
  • Austal Ltd (ASB AU) rejected (for now) Hanwha Ocean (042660 KS)‘s bid based on regulatory concerns.  Hanwha reckons these should not be an issue.
  • If you can tolerate owning the mobile biz, buy Rakuten (4755 JP) on dips. If not, avoid Rakuten Group and Rakuten Bank short-term; buy Rakuten Bank on larger dips.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Weekly Deals Digest (07 Apr) – Kokusai Electric and more

By | Daily Briefs, ECM

In today’s briefing:

  • Weekly Deals Digest (07 Apr) – Kokusai Electric, HD Hyundai Marine, Langham, Jastec, JSR, Best World
  • Rubrik IPO Preview and Valuation Analysis: 2024’s Hottest SaaS Investment Opportunity


Weekly Deals Digest (07 Apr) – Kokusai Electric, HD Hyundai Marine, Langham, Jastec, JSR, Best World

By Arun George


Rubrik IPO Preview and Valuation Analysis: 2024’s Hottest SaaS Investment Opportunity

By Andrei Zakharov

  • Rubrik, a leading VC-backed security software company, filed for a long-awaited IPO in the United States, with Goldman Sachs, Citigroup, Barclays and Wells Fargo leading the offering. 
  • The technology company is focused on data protection and helps organizations to protect their data and recover it in case of cyberattacks.
  • Rubrik was founded by Bipul Sinha, Arvind Nithrakashyap, Arvind Jain and Soham Mazumdar, and backed by VC investors, including Lightspeed Venture Partners, Greylock Partners and Khosla Ventures.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Top 10 Highlights from the APAC PE, VC and Startup Ecosystem this Week – 07 Apr 2024

By | Private Markets, Smartkarma Newswire

Top ten highlights from the APAC PE, VC, and startup ecosystem this week:

  1. Indonesia Investment Authority partners with Global Infrastructure Partners for infrastructure investments in the country.
  2. Dymon Asia Private Equity is in the market to raise capital for its fourth fund.
  3. Fullerton Fund Management doubles down on Asia’s decarbonisation agenda.
  4. New York State Common Retirement Fund commits $150 million to B Capital’s opportunities vehicle.
  5. Granite Asia is the rebranded GGV Capital Asia.
  6. MDI Ventures intensifies focus on impact and ESG-aligned sectors.
  7. PAG-backed Nuvama Group aims to raise up to $479 million for a crossover fund.
  8. DFC approves a $10 million commitment to India-focused VC firm Iron Pillar.
  9. HealthQuad optimistic about exit opportunities in India despite macroeconomic headwinds.
  10. Bitkraft Ventures launches a $275 million venture fund with allocation for Asian startups.

APAC Private Markets Research

Explore latest Insights on APAC Private Markets on Smartkarma


Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars

Also, check out the latest in ECM Research on Smartkarma